Dexbrompheniramine + Dextromethorphan + Phenylephrine
Composition
This formulation contain combination of Dexbrompheniramine, Dextromethorphan and Phenylephrine as active agents
Indications
the symptomatic relief of nasal congestion, cough, and associated symptoms of upper respiratory tract infections
Side effects
drowsiness, dizziness, dry mouth, constipation, and blurred vision
Precautions
used with caution in individuals with a history of cardiovascular disease, hypertension, or hyperthyroidism
Contraindications
in individuals receiving monoamine oxidase inhibitors (MAOIs) or selective serotonin reuptake inhibitors
Dosage and administration
directed by a healthcare professional
Countries
Available Forms
Tablet, Capsule, Syrup
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai